XML 31 R18.htm IDEA: XBRL DOCUMENT v3.26.1
Note 7 - Goodwill
 12 Months Ended
Jan. 03, 2026
Notes to Financial Statements  
Goodwill Disclosure [Text Block]

7.

GOODWILL

 

Goodwill represents the premium paid over the fair value of the net tangible and intangible assets acquired in business combinations. The Company tests goodwill for impairment on an annual basis as of the last day of the Company's fiscal year, or more frequently if events or circumstances indicate that the fair value of goodwill may be below its carrying amount. The Company reviewed industry and market conditions, reported unit-specific events, and overall financial performance, and determined that no indicators of impairment of goodwill existed during the fiscal year ended January 3, 2026. As a result of such review, no impairment loss was recorded for the Company’s intangible assets during the fiscal year ended January 3, 2026. With respect to the fiscal year ended December 28, 2024, since the Company remeasured contingent consideration associated with its Life Sciences, Data, and Solutions segment in fiscal 2024, the Company determined that further testing was necessary. After comparing the fair value of the Life Sciences, Data and Solutions segment to its carrying amount, the Company determined that no impairment loss occurred for the Company’s goodwill related to that segment during the fiscal year ended December 28, 2024.

 

There were no changes in the carrying amount of goodwill for the fiscal years ended January 3, 2026 and December 28, 2024. The amounts by the Company’s segments are as follows:

 

  

Engineering

  

Specialty

Health Care

  

Life

Sciences,

Data &

Solutions

  

Total

 

Balance as of January 3, 2026

 $11,918  $2,398  $7,831  $22,147